Biogen held a ceremonial groundbreaking for the first private development in MIT’s three-million-square-foot Kendall Common in Cambridge, MA. The new Biogen headquarters at 75 Broadway will consolidate the biotech company’s scattered-site local operations into a single 580,000-square-foot, 16-story building.
“Helping to ensure that Biogen stays in Cambridge was very important to us,” SVP Patrick Rowe in MIT’s real estate group said in March when the company announced its new headquarters. “The company’s nearly 50-year history is a foundational component of the Kendall Square innovation ecosystem.” Biogen plans to move into 75 Broadway in 2028, the 50th anniversary of its founding.
At full buildout, the 10-acre Kendall Common development will include eight buildings for residential, office, lab, retail, and community uses. The project’s 10-year review process and federal agreement led to the recent opening of the MIT-built John A. Volpe National Transportation Systems Center, according to MIT.
The post Biogen Breaks Ground on Kendall Common Headquarters appeared first on Connect CRE.